{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:31:06Z","timestamp":1778931066270,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T00:00:00Z","timestamp":1560556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T00:00:00Z","timestamp":1560556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"BILTEMA Foundation"},{"name":"Nexttobe"},{"name":"Stichting af Jochnicks"},{"DOI":"10.13039\/501100009788","name":"Sten A Olssons Stiftelse f\u00f6r Forskning och Kultur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009788","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Familjen Erling-Perssons Foundation"},{"name":"RATOS"},{"name":"independent grants from Hoffmann La Roche"},{"name":"Torsten and Ragnar S\u00f6derbergs Foundations"},{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007508","name":"Stiftelsen Sigurd and Elsa Goljes Minne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007508","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Magnus Bergvalls Foundation"},{"DOI":"10.13039\/501100003748","name":"Swedish Society for Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Percy Falks Foundation"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IngaBritt och Arne Lundbergs Foundation"},{"name":"Tore Nilsons Foundation"},{"name":"the regional health administration (Helse S\u00f8r-\u00d8st),"},{"name":"internal research funds of Akerhus University Hospital"},{"name":"Bodil and Magne\u00b4s Cancer Research Fund"},{"name":"Dan och Jane Olssons Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00432-019-02946-8","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T17:02:21Z","timestamp":1560618141000},"page":"2083-2095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer"],"prefix":"10.1007","volume":"145","author":[{"given":"Helena","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Touma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belghis","family":"Davoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Benard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torill","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Vetvik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-2512","authenticated-orcid":false,"given":"Afsar","family":"Rahbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"S\u00f6derberg-Naucler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,15]]},"reference":[{"key":"2946_CR1","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2174\/1381612023394935","volume":"8","author":"WF Anderson","year":"2002","unstructured":"Anderson WF, Umar A, Viner JL, Hawk ET (2002) The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des 8:1035\u20131062","journal-title":"Curr Pharm Des"},{"key":"2946_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1053\/j.seminoncol.2004.03.042","volume":"31","author":"B Arun","year":"2004","unstructured":"Arun B, Goss P (2004) The role of COX-2 inhibition in breast cancer treatment and prevention. Semin Oncol 31:22\u201329","journal-title":"Semin Oncol"},{"key":"2946_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.breast.2010.07.004","volume":"20","author":"V Ashok","year":"2011","unstructured":"Ashok V, Dash C, Rohan TE, Sprafka JM, Terry PD (2011) Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk. Breast 20:66\u201370. \n                              https:\/\/doi.org\/10.1016\/j.breast.2010.07.004","journal-title":"Breast"},{"key":"2946_CR4","doi-asserted-by":"publisher","DOI":"10.1096\/fj.00-0866fje","author":"I Avis","year":"2001","unstructured":"Avis I et al (2001) Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. \n                              https:\/\/doi.org\/10.1096\/fj.00-0866fje","journal-title":"FASEB J"},{"key":"2946_CR5","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/eurheartj\/ehr421","volume":"33","author":"M Back","year":"2012","unstructured":"Back M, Yin L, Ingelsson E (2012) Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib. Eur Heart J 33:1928\u20131933. \n                              https:\/\/doi.org\/10.1093\/eurheartj\/ehr421","journal-title":"Eur Heart J"},{"key":"2946_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","volume":"7","author":"F Balkwill","year":"2005","unstructured":"Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211\u2013217. \n                              https:\/\/doi.org\/10.1016\/j.ccr.2005.02.013","journal-title":"Cancer Cell"},{"key":"2946_CR7","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1172\/JCI57147","volume":"121","author":"N Baryawno","year":"2011","unstructured":"Baryawno N et al (2011) Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest 121:4043\u20134055. \n                              https:\/\/doi.org\/10.1172\/JCI57147","journal-title":"J Clin Invest"},{"key":"2946_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.placenta.2014.03.022","volume":"35","author":"M Benard","year":"2014","unstructured":"Benard M et al (2014) Human cytomegalovirus infection induces leukotriene B4 and 5-lipoxygenase expression in human placentae and umbilical vein endothelial cells. Placenta 35:345\u2013350. \n                              https:\/\/doi.org\/10.1016\/j.placenta.2014.03.022","journal-title":"Placenta"},{"key":"2946_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11010-010-0682-4","volume":"350","author":"C Bocca","year":"2011","unstructured":"Bocca C, Bozzo F, Bassignana A, Miglietta A (2011) Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines. Mol Cell Biochem 350:59\u201370. \n                              https:\/\/doi.org\/10.1007\/s11010-010-0682-4","journal-title":"Mol Cell Biochem"},{"key":"2946_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1084\/jem.188.5.855","volume":"188","author":"B Bodaghi","year":"1998","unstructured":"Bodaghi B et al (1998) Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188:855\u2013866","journal-title":"J Exp Med"},{"key":"2946_CR11","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1172\/JCI42563","volume":"120","author":"G Bongers","year":"2010","unstructured":"Bongers G et al (2010) The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. J Clin Invest 120:3969\u20133978. \n                              https:\/\/doi.org\/10.1172\/jci42563","journal-title":"J Clin Invest"},{"key":"2946_CR12","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","volume":"378","author":"J Burn","year":"2011","unstructured":"Burn J et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378:2081\u20132087. \n                              https:\/\/doi.org\/10.1016\/s0140-6736(11)61049-0","journal-title":"Lancet"},{"key":"2946_CR13","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3892\/or.2015.4506","volume":"35","author":"XH Che","year":"2016","unstructured":"Che XH et al (2016) Dual inhibition of COX-2\/5-LOX blocks colon cancer proliferation, migration and invasion in vitro. Oncol Rep 35:1680\u20131688. \n                              https:\/\/doi.org\/10.3892\/or.2015.4506","journal-title":"Oncol Rep"},{"key":"2946_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.prostaglandins.2011.08.005","volume":"96","author":"EP Chen","year":"2011","unstructured":"Chen EP, Smyth EM (2011) COX-2 and PGE2-dependent immunomodulation in breast cancer. Prostaglandins Other Lipid Mediators 96:14\u201320. \n                              https:\/\/doi.org\/10.1016\/j.prostaglandins.2011.08.005","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"2946_CR15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s12032-014-0989-1","volume":"31","author":"B Chikman","year":"2014","unstructured":"Chikman B et al (2014) COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients. Med Oncol 31:989. \n                              https:\/\/doi.org\/10.1007\/s12032-014-0989-1","journal-title":"Med Oncol"},{"key":"2946_CR16","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1158\/1535-7163.MCT-06-0318","volume":"5","author":"F Cianchi","year":"2006","unstructured":"Cianchi F et al (2006) Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells. Mol Cancer Ther 5:2716\u20132726. \n                              https:\/\/doi.org\/10.1158\/1535-7163.mct-06-0318","journal-title":"Mol Cancer Ther"},{"key":"2946_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.femsre.2003.07.005","volume":"28","author":"J Cinatl Jr","year":"2004","unstructured":"Cinatl J Jr, Vogel JU, Kotchetkov R, Wilhelm Doerr H (2004a) Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. FEMS Microbiol Rev 28:59\u201377. \n                              https:\/\/doi.org\/10.1016\/j.femsre.2003.07.005","journal-title":"FEMS Microbiol Rev"},{"key":"2946_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molmed.2003.11.002","volume":"10","author":"J Cinatl","year":"2004","unstructured":"Cinatl J, Scholz M, Kotchetkov R, Vogel JU, Doerr HW (2004b) Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med 10:19\u201323","journal-title":"Trends Mol Med"},{"key":"2946_CR19","first-page":"3347","volume":"62","author":"CS Cobbs","year":"2002","unstructured":"Cobbs CS et al (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347\u20133350","journal-title":"Cancer Res"},{"key":"2946_CR20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867. \n                              https:\/\/doi.org\/10.1038\/nature01322","journal-title":"Nature"},{"key":"2946_CR21","doi-asserted-by":"crossref","unstructured":"de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24\u201337. \n                              http:\/\/www.nature.com\/nrc\/journal\/v6\/n1\/suppinfo\/nrc1782_S1.html","DOI":"10.1038\/nrc1782"},{"key":"2946_CR22","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/cncr.11437","volume":"97","author":"C Denkert","year":"2003","unstructured":"Denkert C et al (2003) Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer 97:2978\u20132987. \n                              https:\/\/doi.org\/10.1002\/cncr.11437","journal-title":"Cancer"},{"key":"2946_CR23","first-page":"4947","volume":"33","author":"J Dimberg","year":"2013","unstructured":"Dimberg J, Hong TT, Skarstedt M, Lofgren S, Zar N, Matussek A (2013) Detection of cytomegalovirus DNA in colorectal tissue from Swedish and Vietnamese patients with colorectal cancer. Anticancer Res 33:4947\u20134950","journal-title":"Anticancer Res"},{"key":"2946_CR24","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1200\/JCO.2007.13.3744","volume":"26","author":"LY Dirix","year":"2008","unstructured":"Dirix LY et al (2008) Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib. J Clin Oncol 26:1253\u20131259. \n                              https:\/\/doi.org\/10.1200\/JCO.2007.13.3744","journal-title":"J Clin Oncol"},{"key":"2946_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0005-2760(86)90145-1","volume":"878","author":"KW Dreyling","year":"1986","unstructured":"Dreyling KW, Hoppe U, Peskar BA, Morgenroth K, Kozuschek W, Peskar BM (1986) Leukotriene synthesis by human gastrointestinal tissues. Biochim Biophys Acta 878:184\u2013193","journal-title":"Biochim Biophys Acta"},{"key":"2946_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11060-006-9248-4","volume":"82","author":"DF Flavin","year":"2007","unstructured":"Flavin DF (2007) A lipoxygenase inhibitor in breast cancer brain metastases. J Neurooncol 82:91\u201393. \n                              https:\/\/doi.org\/10.1007\/s11060-006-9248-4","journal-title":"J Neurooncol"},{"key":"2946_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-62703-788-4_3","volume":"1119","author":"G Frascaroli","year":"2014","unstructured":"Frascaroli G, Sinzger C (2014) Distinct properties of human cytomegalovirus strains and the appropriate choice of strains for particular studies. Methods Mol Biol 1119:29\u201346. \n                              https:\/\/doi.org\/10.1007\/978-1-62703-788-4_3","journal-title":"Methods Mol Biol"},{"key":"2946_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12282-016-0723-2","volume":"24","author":"S Gautam","year":"2017","unstructured":"Gautam S, Roy S, Ansari MN, Saeedan AS, Saraf SA, Kaithwas G (2017) DuCLOX-2\/5 inhibition: a promising target for cancer chemoprevention. Breast Cancer 24:180\u2013190. \n                              https:\/\/doi.org\/10.1007\/s12282-016-0723-2","journal-title":"Breast Cancer"},{"key":"2946_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1471-2407-7-138","volume":"7","author":"R Hammamieh","year":"2007","unstructured":"Hammamieh R, Sumaida D, Zhang X, Das R, Jett M (2007) Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism. BMC Cancer 7:138. \n                              https:\/\/doi.org\/10.1186\/1471-2407-7-138","journal-title":"BMC Cancer"},{"key":"2946_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. \n                              https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"2946_CR31","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S0140-6736(02)11524-8","volume":"360","author":"L Harkins","year":"2002","unstructured":"Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS (2002) Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:1557\u20131563. \n                              https:\/\/doi.org\/10.1016\/S0140-6736(02)11524-8","journal-title":"Lancet"},{"key":"2946_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2042-4280-1-8","volume":"1","author":"LE Harkins","year":"2010","unstructured":"Harkins LE et al (2010) Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae 1:8. \n                              https:\/\/doi.org\/10.1186\/2042-4280-1-8","journal-title":"Herpesviridae"},{"key":"2946_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2407-6-27","volume":"6","author":"RE Harris","year":"2006","unstructured":"Harris RE, Beebe-Donk J, Alshafie GA (2006) Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 6:27. \n                              https:\/\/doi.org\/10.1186\/1471-2407-6-27","journal-title":"BMC Cancer"},{"key":"2946_CR34","doi-asserted-by":"publisher","first-page":"677","DOI":"10.5306\/wjco.v5.i4.677","volume":"5","author":"RE Harris","year":"2014","unstructured":"Harris RE, Casto BC, Harris ZM (2014) Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol 5:677\u2013692. \n                              https:\/\/doi.org\/10.5306\/wjco.v5.i4.677","journal-title":"World J Clin Oncol"},{"key":"2946_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0002-9440(10)64198-3","volume":"161","author":"R Hennig","year":"2002","unstructured":"Hennig R et al (2002) 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am J Pathol 161:421\u2013428","journal-title":"Am J Pathol"},{"key":"2946_CR36","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.micinf.2006.04.010","volume":"8","author":"JJ Hooks","year":"2006","unstructured":"Hooks JJ et al (2006) Human cytomegalovirus induced cyclooxygenase-2 in human retinal pigment epithelial cells augments viral replication through a prostaglandin pathway. Microbes Infect 8:2236\u20132244. \n                              https:\/\/doi.org\/10.1016\/j.micinf.2006.04.010","journal-title":"Microbes Infect"},{"key":"2946_CR37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/bcr1678","volume":"9","author":"LR Howe","year":"2007","unstructured":"Howe LR (2007) Inflammation and breast cancer. Cyclooxygenase\/prostaglandin signaling and breast cancer. Breast Cancer Res 9:210. \n                              https:\/\/doi.org\/10.1186\/bcr1678","journal-title":"Breast Cancer Res"},{"key":"2946_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390. \n                              https:\/\/doi.org\/10.3322\/caac.20107","journal-title":"CA Cancer J Clin"},{"key":"2946_CR39","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1073\/pnas.97.4.1695","volume":"97","author":"SV Kotenko","year":"2000","unstructured":"Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S (2000) Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 97:1695\u20131700","journal-title":"Proc Natl Acad Sci USA"},{"key":"2946_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ebiom.2018.03.015","volume":"30","author":"A Kumar","year":"2018","unstructured":"Kumar A et al (2018) The human cytomegalovirus strain DB activates oncogenic pathways in mammary epithelial cells. EBioMedicine 30:167\u2013183. \n                              https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.015","journal-title":"EBioMedicine"},{"key":"2946_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11060-010-0383-6","volume":"103","author":"KG Lucas","year":"2011","unstructured":"Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C (2011) The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol 103:231\u2013238. \n                              https:\/\/doi.org\/10.1007\/s11060-010-0383-6","journal-title":"J Neurooncol"},{"key":"2946_CR42","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.2174\/138161207781368774","volume":"13","author":"J Martinez-Gonzalez","year":"2007","unstructured":"Martinez-Gonzalez J, Badimon L (2007) Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks. Curr Pharm Des 13:2215\u20132227","journal-title":"Curr Pharm Des"},{"key":"2946_CR43","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1158\/0008-5472.CAN-08-2487","volume":"69","author":"D Maussang","year":"2009","unstructured":"Maussang D et al (2009) The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res 69:2861\u20132869. \n                              https:\/\/doi.org\/10.1158\/0008-5472.can-08-2487","journal-title":"Cancer Res"},{"key":"2946_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3892\/mco.2014.327","volume":"2","author":"K Mosalpuria","year":"2014","unstructured":"Mosalpuria K et al (2014) Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients. Mol Clin Oncol 2:845\u2013850. \n                              https:\/\/doi.org\/10.3892\/mco.2014.327","journal-title":"Mol Clin Oncol"},{"key":"2946_CR45","doi-asserted-by":"publisher","first-page":"e63451","DOI":"10.1371\/journal.pone.0063451","volume":"8","author":"YR Na","year":"2013","unstructured":"Na YR, Yoon YN, Son DI, Seok SH (2013) Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model. PLoS One 8:e63451. \n                              https:\/\/doi.org\/10.1371\/journal.pone.0063451","journal-title":"PLoS One"},{"key":"2946_CR46","unstructured":"Petrucelli N, Daly MB, Pal T (1993) BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) GeneReviews((R)). Seattle, WA"},{"key":"2946_CR47","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2174\/1573406410602060591","volume":"2","author":"D Poeckel","year":"2006","unstructured":"Poeckel D et al (2006) Inhibition of human 5-lipoxygenase and anti-neoplastic effects by 2-amino-1,4-benzoquinones. Med Chem 2:591\u2013595","journal-title":"Med Chem"},{"key":"2946_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1084\/jem.20070201","volume":"205","author":"H Qiu","year":"2008","unstructured":"Qiu H, Straat K, Rahbar A, Wan M, Soderberg-Naucler C, Haeggstrom JZ (2008) Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells. J Exp Med 205:19\u201324. \n                              https:\/\/doi.org\/10.1084\/jem.20070201","journal-title":"J Exp Med"},{"key":"2946_CR49","doi-asserted-by":"publisher","first-page":"e982391","DOI":"10.4161\/2162402X.2014.982391","volume":"4","author":"A Rahbar","year":"2015","unstructured":"Rahbar A et al (2015) Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV. Oncoimmunology 4:e982391. \n                              https:\/\/doi.org\/10.4161\/2162402x.2014.982391","journal-title":"Oncoimmunology"},{"issue":"7","key":"2946_CR50","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.clbc.2017.04.013","volume":"17","author":"A Rahbar","year":"2017","unstructured":"Rahbar A et al (2017) Low expression of estrogen receptor-alpha and progesterone receptor in human breast cancer tissues is associated with high-grade human cytomegalovirus protein expression. Clin Breast Cancer 17(7):526\u2013535. \n                              https:\/\/doi.org\/10.1016\/j.clbc.2017.04.013","journal-title":"Clin Breast Cancer"},{"key":"2946_CR51","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1073\/pnas.0408994102","volume":"102","author":"MB Reeves","year":"2005","unstructured":"Reeves MB, MacAry PA, Lehner PJ, Sissons JGP, Sinclair JH (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 102:4140\u20134145. \n                              https:\/\/doi.org\/10.1073\/pnas.0408994102","journal-title":"Proc Natl Acad Sci USA"},{"key":"2946_CR52","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/01.ju.0000080263.46164.97","volume":"170","author":"M Samanta","year":"2003","unstructured":"Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS (2003) High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170:998\u20131002. \n                              https:\/\/doi.org\/10.1097\/01.ju.0000080263.46164.97","journal-title":"J Urol"},{"key":"2946_CR53","doi-asserted-by":"publisher","first-page":"19468","DOI":"10.1073\/pnas.0810740105","volume":"105","author":"J Schroer","year":"2008","unstructured":"Schroer J, Shenk T (2008) Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc Natl Acad Sci USA 105:19468\u201319473. \n                              https:\/\/doi.org\/10.1073\/pnas.0810740105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2946_CR54","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1503\/cmaj.1041606","volume":"171","author":"B Sibbald","year":"2004","unstructured":"Sibbald B (2004) Rofecoxib (Vioxx) voluntarily withdrawn from market. CMAJ 171:1027\u20131028. \n                              https:\/\/doi.org\/10.1503\/cmaj.1041606","journal-title":"CMAJ"},{"key":"2946_CR55","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s12032-011-9995-8","volume":"29","author":"HC Silva","year":"2012","unstructured":"Silva HC, Alves V, Nogueira LA, Rosa MS, Carvalho L, Regateiro F (2012) Impairment of breast cancer cell invasion by COX-2-specific inhibitor NS398: roles of CXCR1 and of uPA system. Med Oncol 29:1468\u20131476. \n                              https:\/\/doi.org\/10.1007\/s12032-011-9995-8","journal-title":"Med Oncol"},{"key":"2946_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2001180","author":"E Slinger","year":"2010","unstructured":"Slinger E (2010) HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal. \n                              https:\/\/doi.org\/10.1126\/scisignal.2001180","journal-title":"Sci Signal"},{"key":"2946_CR57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0092-8674(01)80014-3","volume":"91","author":"C S\u00f6derberg-Naucl\u00e9r","year":"1997","unstructured":"S\u00f6derberg-Naucl\u00e9r C, Fish KN, Nelson JA (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119\u2013126. \n                              https:\/\/doi.org\/10.1016\/S0092-8674(01)80014-3","journal-title":"Cell"},{"key":"2946_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.virusres.2010.10.026","volume":"157","author":"L Soroceanu","year":"2011","unstructured":"Soroceanu L, Cobbs CS (2011) Is HCMV a tumor promoter? Virus Res 157:193\u2013203. \n                              https:\/\/doi.org\/10.1016\/j.virusres.2010.10.026","journal-title":"Virus Res"},{"key":"2946_CR59","first-page":"467","volume":"8","author":"VE Steele","year":"1999","unstructured":"Steele VE et al (1999) Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomark Prev 8:467\u2013483","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2946_CR60","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.7314\/APJCP.2014.15.3.1453","volume":"15","author":"F Tafvizi","year":"2014","unstructured":"Tafvizi F, Fard ZT (2014) Detection of human cytomegalovirus in patients with colorectal cancer by nested-PCR. Asian Pac J Cancer Prev 15:1453\u20131457","journal-title":"Asian Pac J Cancer Prev"},{"key":"2946_CR61","doi-asserted-by":"publisher","first-page":"e56795","DOI":"10.1371\/journal.pone.0056795","volume":"8","author":"C Taher","year":"2013","unstructured":"Taher C et al (2013) High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PLoS One 8:e56795. \n                              https:\/\/doi.org\/10.1371\/journal.pone.0056795","journal-title":"PLoS One"},{"key":"2946_CR62","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.tranon.2014.09.008","volume":"7","author":"C Taher","year":"2014","unstructured":"Taher C et al (2014) High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers. Transl Oncol 7:732\u2013740. \n                              https:\/\/doi.org\/10.1016\/j.tranon.2014.09.008","journal-title":"Transl Oncol"},{"key":"2946_CR63","doi-asserted-by":"publisher","first-page":"c7086","DOI":"10.1136\/bmj.c7086","volume":"342","author":"S Trelle","year":"2011","unstructured":"Trelle S et al (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342:c7086. \n                              https:\/\/doi.org\/10.1136\/bmj.c7086","journal-title":"BMJ"},{"key":"2946_CR64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00432-006-0141-5","volume":"133","author":"J-H Tsai","year":"2007","unstructured":"Tsai J-H et al (2007) Relationship between viral factors, axillary lymph node status and survival in breast cancer. J Cancer Res Clin Oncol 133:13\u201321. \n                              https:\/\/doi.org\/10.1007\/s00432-006-0141-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"2946_CR65","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00251-002-0493-1","volume":"54","author":"MT Vossen","year":"2002","unstructured":"Vossen MT, Westerhout EM, Soderberg-Naucler C, Wiertz EJ (2002) Viral immune evasion: a masterpiece of evolution. Immunogenetics 54:527\u2013542. \n                              https:\/\/doi.org\/10.1007\/s00251-002-0493-1","journal-title":"Immunogenetics"},{"key":"2946_CR66","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, DuBois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181\u2013193","journal-title":"Nat Rev Cancer"},{"key":"2946_CR67","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1002\/ijc.28265","volume":"133","author":"N Wolmer-Solberg","year":"2013","unstructured":"Wolmer-Solberg N et al (2013) Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target? Int J Cancer 133:2351\u20132361. \n                              https:\/\/doi.org\/10.1002\/ijc.28265","journal-title":"Int J Cancer"},{"key":"2946_CR68","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00001813-200202000-00003","volume":"13","author":"XC Xu","year":"2002","unstructured":"Xu XC (2002) COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs 13:127\u2013137","journal-title":"Anticancer Drugs"},{"key":"2946_CR69","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1073\/pnas.052713799","volume":"99","author":"H Zhu","year":"2002","unstructured":"Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE (2002) Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci USA 99:3932\u20133937. \n                              https:\/\/doi.org\/10.1073\/pnas.052713799","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-02946-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T23:07:59Z","timestamp":1592089679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-02946-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,15]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2946"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-02946-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,15]]},"assertion":[{"value":"26 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest and that the results presented in this paper have not been published previously. This cohort of breast cancer patients was previously investigated for HCMV protein expression and association with estrogen receptor-alpha (ER) and progesterone receptor (PGR) expression and the results were reported earlier (Rahbar et al. ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All patients gave their written informed consent prior to inclusion. The study protocol was approved by the regional ethical committee of south-east Norway, Oslo, Norway (2008\/628-31\/2, 577-06-04148, 06118 and 2014\/895) and by the ethical committee at the Karolinska Institutet (Dnr: 2008\/628-31\/2), Stockholm, Sweden. Placental tissues were obtained after informed parental consent and according to the procedures approved by the Regulations of the French Ministry of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}